HHS Slams Slams ARNM technology as Trump cuts the financing of the modern vaccine

President Donald Trump’s Department of Health and Human Services (HHS) ends the prizes for more than $ 750 million that were provided to the modern pharmaceutical manufacturer to help facilitate the production of ARNM -based Birds’ flu vaccines.

During the last week of President Biden in office, his administration granted $ 590 million to Modern to help accelerate his mRNA -based production. The $ 590 million prize followed a separate $ 176 million prize that Biden donated to modern in the beginning of last year for ARNM vaccine technology.

Messenger RNA vaccines are a most recent type of technology, which was used by companies like Moderna and Pfizer to develop their Covid-19 vaccines. The technology of the vaccine was at the center of many criticism in the midst of the pandemic of Coronavirus for being associated with adverse side effects in some people who took them, such as myocarditis.

The military spouse and the mother of 5 struggles as vaccine disputes block the permanent change of the family station

Trump administration officials previously unveiled the potential that this funding could be completed, citing a lack of supervision during the Biden administration related to vaccine production.

“After a rigorous review, we concluded that the continuous investment in the H5N1 modern mRNA vaccine was not scientifically or ethically justifiable,” said HHS communications director Andrew Nixon. “This is not simply effective: this is security, integrity and confidence. The reality is that ARNM technology is still despised and we will not spend dollars of taxpayers by repeating the mistakes of the last administration, which hid the legitimate security problems of the public.”

The protesters opposed the Mandates of the Covid-19 vaccine and the passports of the vaccine by the Government Government in the City Council of New York on August 25, 2021. (Angela Weiss/AFP)

Approval of the Trump FDA COVID-19 review vaccine to focus on older populations, high-risk individuals

The announcement reflects a greater change in the priorities of the federal vaccine, after the HHS secretary, Robert F. Kennedy Jr.

In the meantime, a report by the Republicans of the Senate published earlier this month suggested that the Biden administration retained critical security data and decreased the known risks related to the MRNA Covid-19 vaccine. In particular, the Senate report focuses on HHS awareness and response and the response to cases of myocarditis-a type of heart inflammation-after Covid-19 vaccination.

HHS Secretary Robert F. Kennedy Jr. announced earlier this week that the federal government would eliminate the COVID-19 vaccine-19 vaccine vaccine on the federally recommended vaccine list for pregnant children and women. (Getty Images/Fox News)

“ Instead of providing public and public public and transparent information suppliers on the risk of myocarditis after the vaccination of the COVID-19 mRNA, the Biden administration waited until the end of June 2021 to announce changes to the modern labels and PFIZER COVID-19 vaccines based on the “ increased suggestion of myocarditis risks and pericarditis ”, The Senate reports.

Click here to get the Fox News app

In response to the financing termination of the Trump Administration, Moderna published a statement that acknowledged the move, but also the “security profile” was observed in the midst of his work in a new ARNM Birds flu vaccine.

“Although the end of the financing of HHS brings uncertainty, we are pleased with the sturdy immune response and the security profile observed in this provisional analysis of the study of phase 1 of our Aviari Flu’s vaccine H5 and we will explore alternative paths forward for the program,” said Stéphane Banel, executive director of Moderna. “This clinical data of pandemic flu emphasizes the critical role that ARNM technology has had as opposed to emerging health threats.”

Fox News Digital Brooke Singman contributed to this report.